🇺🇸 FDA
Patent

US 9012223

Methods for enhancing genome stability and telomere elongation in embryonic stem cells

granted A61PA61P25/00A61P35/00

Quick answer

US patent 9012223 (Methods for enhancing genome stability and telomere elongation in embryonic stem cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P25/00, A61P35/00, A61P37/00, A61P37/06